![Marc Augustin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 121 264 $ au 31/05/2026
Marc Augustin currently works at PolyPeptide Group AG, as Chief Financial Officer from 2024.
Mr. Augustin also formerly worked at Lonza AG, as Vice President-Finance and Smith & Nephew Schweiz AG, as Head-Finance from 2009 to 2016.
Mr. Augustin received his undergraduate degree from Heinrich-Heine-Universität Düsseldorf.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG 0,01% | 31/12/2025 | 2 500 ( 0,01% ) | 121 264 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| POLYPEPTIDE GROUP AG | Directeur Financier/CFO | 02/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Smith & Nephew Schweiz AG | Corporate Officer/Principal | 01/01/2016 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Engages in developing, producing and selling pharmaceutical and chemical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lonza AG
Lonza AG BiotechnologyHealth Technology Engages in developing, producing and selling pharmaceutical and chemical products | Health Technology |
Smith & Nephew Schweiz AG | |
PolyPeptide Group AG
 PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
